Latest Lead News

Mount Burgess Mining reports encouraging hydrometallurgical test results from its Nxuu polymetallic deposit, achieving high recoveries for zinc, vanadium, and rare earth elements. The company also completed a modest capital raise to support ongoing project development.

GBM Resources Limited reports significant progress in its exploration programs and asset sales for Q1 2025, including a key Mt Morgan divestment and ongoing farm-in developments at Mt Coolon.

Ausmon Resources advances its rare earth and base metals exploration with new drilling approvals in South Australia and promising zinc assay results near Broken Hill, underpinning its strategic focus on high-value mineral targets.

Imagion Biosystems has progressed its MagSense HER2 breast cancer imaging agent towards a pivotal Investigational New Drug application with the FDA, backed by a solid funding runway exceeding 13 quarters.

InteliCare Holdings has secured a new commercial trial with mecwacare and advanced deployments at Hardi Aged Care sites, underpinning growth in its AI-driven aged care platform amid regulatory changes.

Rincon Resources has reported a maiden mineral resource estimate at its South Telfer Gold-Copper Project, alongside advancing exploration plans at Laverton with new drilling preparations underway.

ENRG Elements Limited has completed a strategic overhaul with new management, significant cost reductions, and a renewed focus on its Agadez Uranium Project, while exiting several lithium assets.

Cobalt Blue Holdings progresses its Kwinana Cobalt Refinery towards a Final Investment Decision while expanding into copper and base metals through the Halls Creek Project. The cobalt market faces a structural shift amid DRC export restrictions, supporting a strategic corporate rebrand and leadership changes.

Noble Helium has postponed its Western margin drilling program and appointed Dennis Donald as Non-Executive Chairman, while actively pursuing refinancing and cost-saving measures to sustain its flagship North Rukwa Project.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

Renascor Resources reports significant engineering advances that increase high-value graphite production by 60%, reduce operating costs, and confirm a safer, eco-friendly purification process.

Australian Gold and Copper Ltd reports strong assay results from its accelerated aircore drilling program at the Achilles Shear Zone, extending the known mineralisation footprint by at least 1.2 kilometres. With $15.7 million cash on hand, the company is poised for further exploration and resource definition.